Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 15 May 2023

Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway

in Pharmacology of Anti-Cancer Drugs

Tong Guo
Xitong Wang
Gensheng Zhang
Tian Xia
Runzhi Zhu
Jinfa Tou

Frontiers in Oncology

doi 10.3389/fonc.2023.1160548

2,545 views
7 citations

Original Research

Published on 12 May 2023

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening

in Pharmacology of Anti-Cancer Drugs

Jun-Zhu Chen
Li-Na Wang
Xue-Qun Luo
Yan-Lai Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178686

4,042 views
2 citations

Systematic Review

Published on 12 May 2023

Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Na Zeng
Meng-Yao Xu
Jian-Xuan Sun
Chen-Qian Liu
Jin-Zhou Xu
Ye An
Xing-Yu Zhong
Si-Yang Ma
Hao-Dong He
Qi-Dong Xia

Frontiers in Oncology

doi 10.3389/fonc.2023.1164932

3,982 views
10 citations

Perspective

Published on 05 May 2023

Should personalised dosing have a role in cancer treatment?

in Pharmacology of Anti-Cancer Drugs

Claire C. Villette
David Orrell
Jim Millen
Christophe Chassagnole

Frontiers in Oncology

doi 10.3389/fonc.2023.1154493

2,335 views
2 citations

Review

Published on 03 May 2023

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review

in Pharmacology of Anti-Cancer Drugs

Andrea Rivero
Pablo Mozas
Laura Magnano
Armando López-Guillermo

Frontiers in Oncology

doi 10.3389/fonc.2023.1170394

8,776 views
8 citations

Original Research

Published on 01 May 2023

Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer

in Pharmacology of Anti-Cancer Drugs

Maodong Hu
Ruifeng Chong
Weilin Liu
Shuangyong Liu
Xiaolei Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1155418

3,319 views
6 citations

Original Research

Published on 18 Apr 2023

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Bin Tang
Min Wu
Lin Zhang
Shuyi Jian
Shiyi Lv
Tongyuan Lin
Shuangshuang Zhu
Layang Liu
Yixue Wang
Zhengfang Yi

Frontiers in Oncology

doi 10.3389/fonc.2023.1154073

2,771 views
8 citations

Original Research

Published on 17 Apr 2023

5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

in Pharmacology of Anti-Cancer Drugs

Xuehua Zhang
Leilei Zhao
Jinlong Xiao
Yudi Wang
Yunmeng Li
Chaoqun Zhu
He Zhang
Yurui Zhang
Xiao Zhu
Yucui Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1143664

3,377 views
3 citations

Perspective

Published on 14 Apr 2023

Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia

in Pharmacology of Anti-Cancer Drugs

Roberta Buono
Muneera Alhaddad
David A. Fruman

Frontiers in Oncology

doi 10.3389/fonc.2023.1162694

3,252 views
3 citations

Correction

Published on 14 Apr 2023

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

in Pharmacology of Anti-Cancer Drugs

Rosalba D’Alessandro
Maria Grazia Refolo
Annalisa Schirizzi
Giampiero De Leonardis
Rossella Donghia
Vito Guerra
Gianluigi Giannelli
Ivan Roberto Lolli
Maria Maddalena Laterza
Ferdinando De Vita

Frontiers in Oncology

doi 10.3389/fonc.2023.1187014

1,063 views
2 citations

Original Research

Published on 14 Apr 2023

Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity

in Pharmacology of Anti-Cancer Drugs

Peng Wang
Zhe Zhang
Wei Cao
Xuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1112369

1,845 views

Review

Published on 13 Apr 2023

Ecological niches for colorectal cancer stem cell survival and thrival

in Pharmacology of Anti-Cancer Drugs

Jiayun Che
Shiyan Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1135364

3,409 views
3 citations

Case Report

Published on 06 Apr 2023

Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report

in Pharmacology of Anti-Cancer Drugs

Xiaoting Ma
Xiu Liu
Kai Ou
Manman Zhang
Lizhen Gao
Lin Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1151178

4,292 views
9 citations

Case Report

Published on 29 Mar 2023

Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib

in Pharmacology of Anti-Cancer Drugs

Xiaoqian Zhai
Ting Wang
Yiyun Lin
Jiabi Zhang
Yuqing Wang
Weiya Wang
Qinghua Zhou
Daxing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1104910

2,127 views

Review

Published on 28 Mar 2023

Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?

in Pharmacology of Anti-Cancer Drugs

Juvin Ann Thomas
Athira Gireesh Gireesh Moly
Hima Xavier
Priya Suboj
Amit Ladha
Gaurav Gupta
Santosh Kumar Singh
Partha Palit
Suboj Babykutty

Frontiers in Oncology

doi 10.3389/fonc.2023.1063051

4,870 views
9 citations

Editorial

Published on 28 Mar 2023

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors

in Pharmacology of Anti-Cancer Drugs

Andrea Cavazzoni
Arianna Palladini

Frontiers in Oncology

doi 10.3389/fonc.2023.1180650

1,424 views
2 citations